Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
147M
-
Number of holders
-
1009
-
Total 13F shares, excl. options
-
187M
-
Shares change
-
+15.1M
-
Total reported value, excl. options
-
$51.2B
-
Value change
-
+$4.11B
-
Put/Call ratio
-
1.21
-
Number of buys
-
459
-
Number of sells
-
-473
-
Price
-
$273.42
Significant Holders of BIOGEN INC. - Common Stock (BIIB) as of Q1 2017
1,167 filings reported holding BIIB - BIOGEN INC. - Common Stock as of Q1 2017.
BIOGEN INC. - Common Stock (BIIB) has 1,009 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 187M shares
.
Largest 10 shareholders include BlackRock Inc. (17.7M shares), PRIMECAP MANAGEMENT CO/CA/ (15.5M shares), VANGUARD GROUP INC (14.4M shares), STATE STREET CORP (9.58M shares), Clearbridge Investments, LLC (9.12M shares), PRICE T ROWE ASSOCIATES INC /MD/ (8.12M shares), WELLINGTON MANAGEMENT GROUP LLP (5.71M shares), FMR LLC (5.54M shares), Invesco Ltd. (4.14M shares), and JPMORGAN CHASE & CO (3.62M shares).
This table shows the top 1009 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.